Kathryn E A Lougheed

Summary

Affiliation: National Institute for Medical Research
Country: UK

Publications

  1. ncbi New anti-tuberculosis agents amongst known drugs
    Kathryn E A Lougheed
    Division of Mycobacterial Research, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom
    Tuberculosis (Edinb) 89:364-70. 2009
  2. ncbi Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents
    Kathryn E A Lougheed
    Division of Mycobacterial Research, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London, NW7 1AA, United Kingdom
    Tuberculosis (Edinb) 91:277-86. 2011

Detail Information

Publications2

  1. ncbi New anti-tuberculosis agents amongst known drugs
    Kathryn E A Lougheed
    Division of Mycobacterial Research, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom
    Tuberculosis (Edinb) 89:364-70. 2009
    ..tuberculosis in a macrophage model of infection. The anti-tuberculosis agents identified in this screen represent promising new scaffolds on which future drug development efforts can be focused...
  2. ncbi Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents
    Kathryn E A Lougheed
    Division of Mycobacterial Research, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London, NW7 1AA, United Kingdom
    Tuberculosis (Edinb) 91:277-86. 2011
    ..Despite a number of drug discovery efforts attempting to develop inhibitors against PknB, it is yet to be reported that any such inhibitors prevent mycobacterial growth at submicromolar concentrations...